Cargando…
Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review
BACKGROUND: Pediatric patients with growth hormone deficiency (GHD) are currently treated with daily injections of recombinant human growth hormone (rhGH) to promote linear growth and enable attainment of normal adult height. One of the main reasons for suboptimal growth during rhGH therapy is non-a...
Autores principales: | Gomez, Roy, Ahmed, S. Faisal, Maghnie, Mohamad, Li, Dejun, Tanaka, Toshiaki, Miller, Bradley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921265/ https://www.ncbi.nlm.nih.gov/pubmed/35299969 http://dx.doi.org/10.3389/fendo.2022.795224 |
Ejemplares similares
-
PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study
por: Gomez, Roy, et al.
Publicado: (2022) -
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
por: Gomez, Roy, et al.
Publicado: (2023) -
Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients
por: Miller, Bradley S, et al.
Publicado: (2022) -
Racial/Ethnic Disparities in the Investigation and Treatment of Pediatric Growth Hormone Deficiency
por: Hawkes, Colin Patrick, et al.
Publicado: (2021) -
OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)